I think you have the Type A meeting and from there it is determined whether it is a Class 1 or Class 2 depending on the re-submission/information provided.
For instance, if the Type A meeting takes 30 days, and MSB provide information that says we are not doing a placebo on children, but approve us for children and we will then do a post-marketing study on adults, then the FDA determine whether that information means the CLR is a Class 1 or Class 2.
MSB clearly think it is a Class 1 as they said that they think they have been delayed 3-4 months. That means 30 days for Type A meeting, and then 2 months for Class 1 decision.
I think that is correct, as it matches timelines and info here....https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr=314.110
- Forums
- ASX - By Stock
- MSB
- MSB to dispute FDA finding in Type A meeting
MSB to dispute FDA finding in Type A meeting, page-172
-
- There are more pages in this discussion • 846 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.19 |
Change
0.000(0.00%) |
Mkt cap ! $1.370B |
Open | High | Low | Value | Volume |
$1.18 | $1.22 | $1.18 | $2.391M | 2.001M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 33262 | $1.19 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.19 | 31 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 13100 | 1.190 |
18 | 42004 | 1.185 |
10 | 89004 | 1.180 |
12 | 156004 | 1.175 |
7 | 52274 | 1.170 |
Price($) | Vol. | No. |
---|---|---|
1.195 | 38877 | 11 |
1.200 | 90475 | 14 |
1.205 | 39716 | 9 |
1.210 | 138792 | 10 |
1.215 | 10111 | 2 |
Last trade - 11.23am 15/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |